Hypertension in adults: summary of updated NICE guidance – The BMJ

Posted: Published on October 23rd, 2019

This post was added by Alex Diaz-Granados

Discuss treatment with people with stage 1 hypertension and a 10 year risk for cardiovascular disease 10%

Choice of antihypertensive drug treatment should take into account patient preferences; a new decision aid has been produced to support this

Consistently maintain blood pressure below target, rather than aim for a target

Existing blood pressure targets have not been lowered; the benefits and harms of lowering them could not be fully determined from current evidence

Asymptomatic, severe hypertension (180/120 mmHg) does not require same day specialist review, but investigations for target organ damage should be carried out as soon as possible

The guideline now makes recommendations for people with type 2 diabetes

Hypertension is a leading global cause of morbidity and mortality. More than 25% of the adult UK population has hypertension, and in about 30% blood pressure remains uncontrolled.1 In August, the National Institute for Health and Care Excellence (NICE) published its updated guideline on the diagnosis and management of hypertension. The guideline reviews further evidence that has emerged since it was last updated in 2011 from randomised trials investigating the initiation, monitoring, and choice of antihypertensive treatment. The scope of the updated guideline has increased to also include people with type 2 diabetes, but does not make recommendations for people with chronic kidney disease, established cardiovascular disease, or hypertension in pregnancy.

This article summarises the most recent recommendations from NICE and includes information considered to be most relevant to primary care clinicians. Key changes to current practice include offering drug treatment to people at a lower threshold for 10 year risk of cardiovascular disease, emphasis on maintaining blood pressure below target, and clarifying criteria for same day specialist review in people with accelerated hypertension.

NICE recommendations are based on systematic reviews of best available evidence and explicit consideration of

See more here:

Hypertension in adults: summary of updated NICE guidance - The BMJ

Related Posts
This entry was posted in Hypertension. Bookmark the permalink.

Comments are closed.